电邮这篇文章 Pazopanib v lechenii rasprostranennogo pochechno-kletochnogo raka (klinicheskiy sluchay)
- 作者: Savkov RV1
-
隶属关系:
- 期: 卷 14, 编号 3 (2012)
- 页面: 16-19
- 栏目: Articles
- ##submission.dateSubmitted##: 09.04.2020
- ##submission.datePublished##: 15.09.2012
- URL: https://modernonco.orscience.ru/1815-1434/article/view/29496
- ID: 29496
如何引用文章
全文:
详细
参考
- Bernard J Escudier, Camillo Porta, Petri Bono et al. Patient preference between pazopanib (Paz) and sunitinib (Sun): Results of a randomized double-blind, placebo-controlled, cross-over study in patients with metastatic renal cell carcinoma (mRCC)-PISCES study, NCT 01064310. J Clin Oncol (Suppl; abstr CRA4502); 2012.
补充文件
